Stock DNA
Pharmaceuticals & Biotechnology
CAD 2,070 Million (Small Cap)
117.00
NA
0.00%
0.56
1.05%
1.17
Revenue and Profits:
Net Sales:
435 Million
(Quarterly Results - Jun 2025)
Net Profit:
1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
34.11%
0%
34.11%
6 Months
25.63%
0%
25.63%
1 Year
23.22%
0%
23.22%
2 Years
96.58%
0%
96.58%
3 Years
27.84%
0%
27.84%
4 Years
-31.64%
0%
-31.64%
5 Years
0%
0%
0.0%
dentalcorp Holdings Ltd. for the last several years.
Risk Adjusted Returns v/s 
News

dentalcorp Holdings Hits Day High with 31.76% Surge in Stock Price
dentalcorp Holdings has seen notable stock activity, rising significantly today and showing strong weekly and monthly gains. The company has reported consistent growth in net sales and operating profit, alongside positive quarterly results. However, its annual performance lags behind the broader market, with a modest return.
Read More Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
12.70%
EBIT Growth (5y)
96.70%
EBIT to Interest (avg)
0.18
Debt to EBITDA (avg)
5.52
Net Debt to Equity (avg)
0.58
Sales to Capital Employed (avg)
0.52
Tax Ratio
19.81%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.33%
ROE (avg)
0.18%
Valuation key factors
Factor
Value
P/E Ratio
117
Industry P/E
Price to Book Value
1.23
EV to EBIT
35.20
EV to EBITDA
10.93
EV to Capital Employed
1.15
EV to Sales
1.96
PEG Ratio
0.76
Dividend Yield
NA
ROCE (Latest)
3.25%
ROE (Latest)
1.05%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
435.20
409.40
6.30%
Operating Profit (PBDIT) excl Other Income
78.40
74.40
5.38%
Interest
21.70
21.00
3.33%
Exceptional Items
-6.90
-11.20
38.39%
Consolidate Net Profit
0.90
-10.20
108.82%
Operating Profit Margin (Excl OI)
74.00%
56.90%
1.71%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 6.30% vs 2.99% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 108.82% vs 22.14% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,545.10
1,425.70
8.37%
Operating Profit (PBDIT) excl Other Income
269.10
246.60
9.12%
Interest
92.20
96.70
-4.65%
Exceptional Items
-38.80
-29.90
-29.77%
Consolidate Net Profit
-59.40
-85.60
30.61%
Operating Profit Margin (Excl OI)
41.70%
30.50%
1.12%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 8.37% vs 14.03% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 30.61% vs -415.66% in Dec 2023
About dentalcorp Holdings Ltd. 
dentalcorp Holdings Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






